# Lockheed Martin Corp: financial statements, quarterly

LMT · NYSE · CIK 936468 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lmt.md) · [Financials](/companies/lmt/financials.md) · [Filings](/companies/lmt/filings.md) · [Insiders](/companies/lmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [18.9 d](/filings/0001628280-26-004195.md) | [17.2](/filings/0000936468-25-000035.md) | [18.1](/filings/0001628280-25-035565.md) | [17.1](/filings/0001628280-25-045693.md) | [18.6 d](/filings/0001628280-26-004195.md) | [18.0](/filings/0001628280-26-026836.md) | [18.2](/filings/0001628280-26-049411.md) | [18.6](/filings/0001628280-26-066928.md) | [20.3 d](/filings/0001628280-26-004195.md) | [18.0](/filings/0001628280-26-026836.md) | [20.1](/filings/0001628280-26-049411.md) | [20.7](/filings/0001628280-26-066928.md) |
| Cost of revenue | $bn | [16.6 d](/filings/0001628280-26-004195.md) | [15.2](/filings/0000936468-25-000035.md) | [16.0](/filings/0001628280-25-035565.md) | [15.0](/filings/0001628280-25-045693.md) | [17.9 d](/filings/0001628280-26-004195.md) | [15.6](/filings/0001628280-26-026836.md) | [17.4](/filings/0001628280-26-049411.md) | [16.4](/filings/0001628280-26-066928.md) | [18.0 d](/filings/0001628280-26-004195.md) | [15.9](/filings/0001628280-26-026836.md) | [17.6](/filings/0001628280-26-049411.md) | [18.3](/filings/0001628280-26-066928.md) |
| Gross profit | $bn | [2.3 d](/filings/0001628280-26-004195.md) | [2.0](/filings/0000936468-25-000035.md) | [2.1](/filings/0001628280-25-035565.md) | [2.1](/filings/0001628280-25-045693.md) | [0.7 d](/filings/0001628280-26-004195.md) | [2.3](/filings/0001628280-26-026836.md) | [0.7](/filings/0001628280-26-049411.md) | [2.2](/filings/0001628280-26-066928.md) | [2.3 d](/filings/0001628280-26-004195.md) | [2.1](/filings/0001628280-26-026836.md) | [2.4](/filings/0001628280-26-049411.md) | [2.4](/filings/0001628280-26-066928.md) |
| Operating income | $bn | [2.3 d](/filings/0001628280-26-004195.md) | [2.0](/filings/0000936468-25-000035.md) | [2.1](/filings/0001628280-25-035565.md) | [2.1](/filings/0001628280-25-045693.md) | [0.7 d](/filings/0001628280-26-004195.md) | [2.4](/filings/0001628280-26-026836.md) | [0.7](/filings/0001628280-26-049411.md) | [2.3](/filings/0001628280-26-066928.md) | [2.3 d](/filings/0001628280-26-004195.md) | [2.1](/filings/0001628280-26-026836.md) | [2.5](/filings/0001628280-26-049411.md) | [2.4](/filings/0001628280-26-066928.md) |
| Interest expense | $bn | [0.3 d](/filings/0000936468-24-000010.md) | [0.3](/filings/0000936468-24-000052.md) | [0.3](/filings/0001628280-25-035565.md) | [0.3](/filings/0001628280-25-045693.md) | [0.3 d](/filings/0001628280-26-004195.md) | [0.3](/filings/0001628280-26-026836.md) | [0.3](/filings/0001628280-26-049411.md) | [0.3](/filings/0001628280-26-066928.md) | [0.3 d](/filings/0001628280-26-004195.md) | [0.3](/filings/0001628280-26-026836.md) | [0.3](/filings/0001628280-26-049411.md) | [0.3](/filings/0001628280-26-066928.md) |
| Income tax | $bn | [0.3 d](/filings/0001628280-26-004195.md) | [0.3](/filings/0000936468-25-000035.md) | [0.3](/filings/0001628280-25-035565.md) | [0.3](/filings/0001628280-25-045693.md) | [(0.0) d](/filings/0001628280-26-004195.md) | [0.3](/filings/0001628280-26-026836.md) | [0.1](/filings/0001628280-26-049411.md) | [0.3](/filings/0001628280-26-066928.md) | [0.2 d](/filings/0001628280-26-004195.md) | [0.3](/filings/0001628280-26-026836.md) | [0.3](/filings/0001628280-26-049411.md) | [0.3](/filings/0001628280-26-066928.md) |
| Net income | $bn | [1.9 d](/filings/0001628280-26-004195.md) | [1.5](/filings/0000936468-25-000035.md) | [1.6](/filings/0001628280-25-035565.md) | [1.6](/filings/0001628280-25-045693.md) | [0.5 d](/filings/0001628280-26-004195.md) | [1.7](/filings/0001628280-26-026836.md) | [0.3](/filings/0001628280-26-049411.md) | [1.6](/filings/0001628280-26-066928.md) | [1.3 d](/filings/0001628280-26-004195.md) | [1.5](/filings/0001628280-26-026836.md) | [1.8](/filings/0001628280-26-049411.md) | [1.8](/filings/0001628280-26-066928.md) |
| Diluted EPS | $ per share | not reported | [6.39](/filings/0000936468-25-000035.md) | [6.85](/filings/0001628280-25-035565.md) | [6.80](/filings/0001628280-25-045693.md) | not reported | [7.28](/filings/0001628280-26-026836.md) | [1.46](/filings/0001628280-26-049411.md) | [6.95](/filings/0001628280-26-066928.md) | not reported | [6.44](/filings/0001628280-26-026836.md) | [7.94](/filings/0001628280-26-049411.md) | [7.97](/filings/0001628280-26-066928.md) |
| Basic EPS | $ per share | not reported | [6.42](/filings/0000936468-25-000035.md) | [6.87](/filings/0001628280-25-035565.md) | [6.83](/filings/0001628280-25-045693.md) | not reported | [7.30](/filings/0001628280-26-026836.md) | [1.46](/filings/0001628280-26-049411.md) | [6.98](/filings/0001628280-26-066928.md) | not reported | [6.47](/filings/0001628280-26-026836.md) | [7.98](/filings/0001628280-26-049411.md) | [8.00](/filings/0001628280-26-066928.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.4](/filings/0000936468-25-000009.md) | [2.8](/filings/0000936468-24-000052.md) | [2.5](/filings/0000936468-24-000095.md) | [3.2](/filings/0000936468-24-000110.md) | [2.5](/filings/0001628280-26-004195.md) | [1.8](/filings/0000936468-25-000035.md) | [1.3](/filings/0001628280-25-035565.md) | [3.5](/filings/0001628280-25-045693.md) | [4.1](/filings/0001628280-26-066928.md) | [1.9](/filings/0001628280-26-026836.md) | [3.8](/filings/0001628280-26-049411.md) | [6.0](/filings/0001628280-26-066928.md) |
| Current assets | $bn | [20.5](/filings/0000936468-25-000009.md) | [23.0](/filings/0000936468-24-000052.md) | [23.0](/filings/0000936468-24-000095.md) | [23.2](/filings/0000936468-24-000110.md) | [21.8](/filings/0001628280-26-004195.md) | [22.8](/filings/0000936468-25-000035.md) | [24.0](/filings/0001628280-25-035565.md) | [25.9](/filings/0001628280-25-045693.md) | [25.4](/filings/0001628280-26-066928.md) | [25.1](/filings/0001628280-26-026836.md) | [28.4](/filings/0001628280-26-049411.md) | [31.0](/filings/0001628280-26-066928.md) |
| Total assets | $bn | [52.5](/filings/0000936468-25-000009.md) | [55.0](/filings/0000936468-24-000052.md) | [55.1](/filings/0000936468-24-000095.md) | [55.5](/filings/0000936468-24-000110.md) | [55.6](/filings/0001628280-26-004195.md) | [56.7](/filings/0000936468-25-000035.md) | [58.9](/filings/0001628280-25-035565.md) | [60.3](/filings/0001628280-25-045693.md) | [59.8](/filings/0001628280-26-066928.md) | [59.2](/filings/0001628280-26-026836.md) | [62.5](/filings/0001628280-26-049411.md) | [64.5](/filings/0001628280-26-066928.md) |
| Current liabilities | $bn | [16.9](/filings/0000936468-25-000009.md) | [17.7](/filings/0000936468-24-000052.md) | [18.5](/filings/0000936468-24-000095.md) | [17.8](/filings/0000936468-24-000110.md) | [19.4](/filings/0001628280-26-004195.md) | [21.2](/filings/0000936468-25-000035.md) | [24.4](/filings/0001628280-25-035565.md) | [23.0](/filings/0001628280-25-045693.md) | [23.3](/filings/0001628280-26-066928.md) | [22.1](/filings/0001628280-26-026836.md) | [23.8](/filings/0001628280-26-049411.md) | [24.5](/filings/0001628280-26-066928.md) |
| Total liabilities | $bn | [45.6](/filings/0000936468-25-000009.md) | [48.3](/filings/0000936468-24-000052.md) | [48.9](/filings/0000936468-24-000095.md) | [48.3](/filings/0000936468-24-000110.md) | [49.3](/filings/0001628280-26-004195.md) | [50.0](/filings/0000936468-25-000035.md) | [53.5](/filings/0001628280-25-035565.md) | [54.1](/filings/0001628280-25-045693.md) | [53.1](/filings/0001628280-26-066928.md) | [51.7](/filings/0001628280-26-026836.md) | [53.7](/filings/0001628280-26-049411.md) | [54.4](/filings/0001628280-26-066928.md) |
| Long-term debt | $bn | [17.3](/filings/0000936468-25-000009.md) | [19.3](/filings/0000936468-24-000052.md) | [19.1](/filings/0000936468-24-000095.md) | [19.2](/filings/0000936468-24-000110.md) | [19.6](/filings/0001628280-26-004195.md) | [18.7](/filings/0000936468-25-000035.md) | [18.5](/filings/0001628280-25-035565.md) | [20.5](/filings/0001628280-25-045693.md) | [20.5](/filings/0001628280-26-066928.md) | [20.5](/filings/0001628280-26-026836.md) | [20.5](/filings/0001628280-26-049411.md) | [20.5](/filings/0001628280-26-066928.md) |
| Current portion of debt | $bn | [0.2](/filings/0000936468-25-000009.md) | [0.2](/filings/0000936468-24-000052.md) | [0.1](/filings/0000936468-24-000095.md) | [0.1](/filings/0000936468-24-000110.md) | [0.6](/filings/0001628280-26-004195.md) | [1.6](/filings/0000936468-25-000035.md) | [3.1](/filings/0001628280-25-035565.md) | [1.7](/filings/0001628280-25-045693.md) | [1.2](/filings/0001628280-26-066928.md) | [0.2](/filings/0001628280-26-026836.md) | [0.0](/filings/0001628280-26-049411.md) | [0.0](/filings/0001628280-26-066928.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [6.8](/filings/0001628280-26-004195.md) | [6.7](/filings/0001628280-25-035565.md) | [6.2](/filings/0001628280-25-045693.md) | [7.2](/filings/0001628280-25-045693.md) | [6.3](/filings/0001628280-26-066928.md) | [6.7](/filings/0001628280-26-049411.md) | [5.3](/filings/0001628280-26-066928.md) | [6.2](/filings/0001628280-26-066928.md) | [6.7](/filings/0001628280-26-066928.md) | [7.5](/filings/0001628280-26-049411.md) | [8.8](/filings/0001628280-26-066928.md) | [10.1](/filings/0001628280-26-066928.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,365 d](/filings/0001628280-26-004195.md) | [1,635](/filings/0000936468-25-000035.md) | [1,876 d](/filings/0001628280-25-035565.md) | [2,438 d](/filings/0001628280-25-045693.md) | [1,023 d](/filings/0001628280-26-004195.md) | [1,409](/filings/0001628280-26-026836.md) | [201 d](/filings/0001628280-26-049411.md) | [3,728 d](/filings/0001628280-26-066928.md) | [3,219 d](/filings/0001628280-26-004195.md) | [220](/filings/0001628280-26-026836.md) | [3,235 d](/filings/0001628280-26-049411.md) | [3,438 d](/filings/0001628280-26-066928.md) |
| Capital expenditure | $m | [704 d](/filings/0001628280-26-004195.md) | [378](/filings/0000936468-25-000035.md) | [370 d](/filings/0001628280-25-035565.md) | [355 d](/filings/0001628280-25-045693.md) | [582 d](/filings/0001628280-26-004195.md) | [454](/filings/0001628280-26-026836.md) | [351 d](/filings/0001628280-26-049411.md) | [381 d](/filings/0001628280-26-066928.md) | [463 d](/filings/0001628280-26-004195.md) | [511](/filings/0001628280-26-026836.md) | [318 d](/filings/0001628280-26-049411.md) | [439 d](/filings/0001628280-26-066928.md) |
| Dividends paid | $m | [767 d](/filings/0001628280-26-004195.md) | [780](/filings/0000936468-25-000035.md) | [752 d](/filings/0001628280-25-035565.md) | [749 d](/filings/0001628280-25-045693.md) | [778 d](/filings/0001628280-26-004195.md) | [796](/filings/0001628280-26-026836.md) | [771 d](/filings/0001628280-26-049411.md) | [765 d](/filings/0001628280-26-066928.md) | [799 d](/filings/0001628280-26-004195.md) | [816](/filings/0001628280-26-026836.md) | [796 d](/filings/0001628280-26-049411.md) | [796 d](/filings/0001628280-26-066928.md) |
| Share repurchases | $m | [3,000 d](/filings/0001628280-26-004195.md) | [1,000](/filings/0000936468-25-000035.md) | [850 d](/filings/0001628280-25-035565.md) | [850 d](/filings/0001628280-25-045693.md) | [1,000 d](/filings/0001628280-26-004195.md) | [750](/filings/0001628280-26-026836.md) | [500 d](/filings/0001628280-26-049411.md) | [1,000 d](/filings/0001628280-26-066928.md) | [750 d](/filings/0001628280-26-004195.md) | [0.0](/filings/0001628280-26-026836.md) | [0.0 d](/filings/0001628280-26-049411.md) | [0.0 d](/filings/0001628280-26-066928.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-26) | Q2 FY2023 (2023-06-25) | Q3 FY2023 (2023-09-24) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [256](/filings/0000936468-24-000052.md) | [254](/filings/0000936468-24-000095.md) | [250](/filings/0000936468-24-000110.md) | [242](/filings/0000936468-25-000035.md) | [240](/filings/0001628280-25-035565.md) | [239](/filings/0001628280-25-045693.md) | [235](/filings/0001628280-26-026836.md) | [234](/filings/0001628280-26-049411.md) | [233](/filings/0001628280-26-066928.md) | [231](/filings/0001628280-26-026836.md) | [231](/filings/0001628280-26-049411.md) | [232](/filings/0001628280-26-066928.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 231,004,640 at 2026-10-19, from the cover of the [10-Q filed 2026-10-22](/filings/0001628280-26-066928.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.